---
figid: PMC4127606__WJCO-5-348-g002
figtitle: Estrogens and growth factor signaling in breast cancer
organisms:
- Homo sapiens
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC4127606
filename: WJCO-5-348-g002.jpg
figlink: /pmc/articles/PMC4127606/figure/F2/
number: F2
caption: Estrogens and growth factor signaling in breast cancer. Mitogenic signals
  from estrogens and growth factors activate PI3K/AKT-Ras-Erk pathway to target estrogen
  receptor (ER). The phosphorylation cascade promotes ER activation. The receptor
  is recruited to a transcription factor (TF) that binds to responsive elements on
  DNA for the corresponding transcriptional responses. Antagonistic actions of tamoxifen
  on ER are shown. Psoralens may act by inhibiting aromatase enzyme, metalloproteinases
  (MMPs) and CYP enzymes. They address antagonistic effects on PI3K/AKT survival signals
  and apoptotic response with the involvement of p53 and p21 waf. Estrogens also bind
  the GPER, a member of the seven-transmembrane G protein-coupled receptor family,
  to trigger proliferative responses.
papertitle: Effects of psoralens as anti-tumoral agents in breast cancer cells.
reftext: Maria Luisa Panno, et al. World J Clin Oncol. 2014 Aug 10;5(3):348-358.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8559191
figid_alias: PMC4127606__F2
figtype: Figure
redirect_from: /figures/PMC4127606__F2
ndex: d4678c15-df1e-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4127606__WJCO-5-348-g002.html
  '@type': Dataset
  description: Estrogens and growth factor signaling in breast cancer. Mitogenic signals
    from estrogens and growth factors activate PI3K/AKT-Ras-Erk pathway to target
    estrogen receptor (ER). The phosphorylation cascade promotes ER activation. The
    receptor is recruited to a transcription factor (TF) that binds to responsive
    elements on DNA for the corresponding transcriptional responses. Antagonistic
    actions of tamoxifen on ER are shown. Psoralens may act by inhibiting aromatase
    enzyme, metalloproteinases (MMPs) and CYP enzymes. They address antagonistic effects
    on PI3K/AKT survival signals and apoptotic response with the involvement of p53
    and p21 waf. Estrogens also bind the GPER, a member of the seven-transmembrane
    G protein-coupled receptor family, to trigger proliferative responses.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - GPER1
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - TP53
  - TP63
  - TP73
  - AKT1
  - AKT2
  - AKT3
  - EPHB2
  - MAPK1
  - MAPK3
  - MTOR
  - TF
  - ras
  - Ras64B
  - Ras85D
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - p53
  - betaTub60D
  - hth
  - Akt
  - Erk7
  - rl
  - Mtor
  - Tor
  - tf
  - Tamoxifen
  - Cancer
---
